VILLANI, ALESSIA
 Distribuzione geografica
Continente #
AS - Asia 5.508
NA - Nord America 3.991
EU - Europa 3.001
SA - Sud America 649
AF - Africa 128
OC - Oceania 10
Continente sconosciuto - Info sul continente non disponibili 3
Totale 13.290
Nazione #
US - Stati Uniti d'America 3.863
SG - Singapore 2.443
RU - Federazione Russa 1.670
CN - Cina 1.074
VN - Vietnam 864
BR - Brasile 518
HK - Hong Kong 489
IT - Italia 483
IN - India 189
DE - Germania 187
FR - Francia 176
NL - Olanda 149
KR - Corea 96
JP - Giappone 94
GB - Regno Unito 74
FI - Finlandia 69
CA - Canada 59
AR - Argentina 52
MX - Messico 48
BD - Bangladesh 44
SE - Svezia 38
CI - Costa d'Avorio 33
PL - Polonia 33
IQ - Iraq 28
TH - Thailandia 26
ZA - Sudafrica 26
IE - Irlanda 24
EC - Ecuador 23
PH - Filippine 21
UA - Ucraina 21
ID - Indonesia 18
TR - Turchia 16
VE - Venezuela 16
PK - Pakistan 14
TW - Taiwan 14
MA - Marocco 12
ES - Italia 11
AT - Austria 10
DZ - Algeria 10
EG - Egitto 10
PY - Paraguay 10
CL - Cile 9
LT - Lituania 9
JO - Giordania 8
OM - Oman 8
UZ - Uzbekistan 8
CO - Colombia 7
MY - Malesia 7
AU - Australia 6
BG - Bulgaria 6
BO - Bolivia 5
CZ - Repubblica Ceca 5
IL - Israele 5
KE - Kenya 5
PE - Perù 5
RO - Romania 5
AZ - Azerbaigian 4
BE - Belgio 4
IR - Iran 4
KZ - Kazakistan 4
NP - Nepal 4
SY - Repubblica araba siriana 4
TN - Tunisia 4
UY - Uruguay 4
AE - Emirati Arabi Uniti 3
CR - Costa Rica 3
DO - Repubblica Dominicana 3
ET - Etiopia 3
HN - Honduras 3
HR - Croazia 3
JM - Giamaica 3
KG - Kirghizistan 3
LB - Libano 3
LV - Lettonia 3
NG - Nigeria 3
PA - Panama 3
CH - Svizzera 2
CM - Camerun 2
DK - Danimarca 2
EE - Estonia 2
GA - Gabon 2
GR - Grecia 2
HU - Ungheria 2
KH - Cambogia 2
LY - Libia 2
ME - Montenegro 2
ML - Mali 2
MN - Mongolia 2
NO - Norvegia 2
NZ - Nuova Zelanda 2
SA - Arabia Saudita 2
SD - Sudan 2
SK - Slovacchia (Repubblica Slovacca) 2
TT - Trinidad e Tobago 2
AL - Albania 1
AM - Armenia 1
AO - Angola 1
BA - Bosnia-Erzegovina 1
BH - Bahrain 1
BS - Bahamas 1
Totale 13.263
Città #
Singapore 1.187
San Jose 755
Hong Kong 474
Hefei 454
Moscow 399
Ashburn 380
Chandler 322
Santa Clara 280
Beijing 242
Ho Chi Minh City 237
Hanoi 191
Dallas 151
Lauterbourg 126
Amsterdam 114
The Dalles 113
Los Angeles 110
Kochi 105
Boston 87
Seoul 85
Lawrence 81
Tokyo 80
Napoli 76
Millbury 70
Redondo Beach 68
Naples 57
Buffalo 55
Des Moines 48
New York 47
São Paulo 44
Helsinki 37
Munich 37
Da Nang 36
Milan 36
Rome 35
Haiphong 33
Wilmington 31
Frankfurt am Main 27
Warsaw 25
Orem 24
Nanjing 23
Seattle 22
Washington 22
Chennai 21
Falkenstein 21
Council Bluffs 20
Mexico City 20
Chicago 19
Atlanta 18
Biên Hòa 18
Brooklyn 18
Düsseldorf 16
Dublin 15
Kronberg 15
Lappeenranta 15
Phoenix 15
Rio de Janeiro 15
Stockholm 15
Houston 14
Turku 14
London 13
Baghdad 12
Guangzhou 12
Hải Dương 12
Johannesburg 12
Montreal 12
Ottawa 12
Toronto 12
Bangkok 11
Brasília 11
Campinas 11
Poplar 11
Quito 11
Fairfield 10
Turin 10
Belo Horizonte 9
Denver 9
Latina 9
Amman 8
Cagliari 8
Cairo 8
Can Tho 8
Curitiba 8
Guarulhos 8
Manchester 8
Quận Bình Thạnh 8
San Francisco 8
Guayaquil 7
New Delhi 7
Nuremberg 7
Querétaro 7
Salvador 7
Tashkent 7
Woodbridge 7
Afragola 6
Boardman 6
Changsha 6
Charlotte 6
Ha Long 6
Nha Trang 6
Portsmouth 6
Totale 7.477
Nome #
Review of oral minoxidil as treatment of hair disorders: in search of the perfect dose 287
A case of the co-existence of subcorneal pustular dermatosis and pyoderma gangrenosum and a review of the literature 200
Therapeutic update of biologics and small molecules for scalp psoriasis: a systematic review 179
Grover disease in a young woman: report of case. 160
Clinical and dermoscopic features of Spitz nevus by sex, age and anatomical site: a study of 913 Spitz naevi 155
Psoriasis Features in Patients with Inflammatory Bowel Disease 149
Leiomyoma of the finger in a patient affected by cutaneous Kaposi's sarcoma 146
Use of Natural Agents and Agrifood Wastes for the Treatment of Skin Photoaging 145
How reflectance confocal microscopy can help diagnose an enigmatic variant of dermatofibroma 144
Squamous Cell Carcinomas in Two Cases of Nail Lichen Planus: Is There a Real Association? 143
Cutaneous leucocytoclastic vasculitis during secukinumab treatment 138
Vismodegib treatment in a HIV positive patient on antiretroviral therapy 136
Efficacy and safety of a new topical gel formulation containing retinol encapsulated in glycospheres and hydroxypinacolone retinoate, an antimicrobial peptide, salicylic acid, glycolic acid and niacinamide for the treatment of mild acne: preliminary results of a 2-month prospective study 135
Adalimumab, Ustekinumab, and Secukinumab in the Management of Hidradenitis Suppurativa: A Review of the Real-Life Experience 133
Neutrophilic dermatosis in pregnancy: An uncommon course 133
Reply to Woltsche N. et al. Managing adverse effects by dose reduction during routine treatment of locally advanced basal cell carcinoma with the hedgehog inhibitor vismodegib: a single center experience 132
Advanced Squamous Cell Carcinoma Developed on Chronic Hidradenitis Suppurativa, Successfully Treated with Cemiplimab: A Case Report 131
Psoriasis in a cohort of patients with common variable immunodeficiency 131
Advanced basal cell carcinoma treated with vismodegib: impact on the lives of patients and their families 131
Teledermoscopy: a promising tool in pediatric practice 130
Effective and tolerable treatment of advanced basal cell carcinoma with vismodegib despite other malignancies 129
Letter to the editor regarding article "Falotico JM, Gu L, Lipner SR. Not just pimple popping: The utility of hybrid telemedicine models beyond acne management amidst the ongoing COVID-19 pandemic. J Cosmet Dermatol. 2022;10.1111/jocd.15256" 128
Cutaneous Bowen’s disease: An analysis of 182 cases according to age, sex, and anatomical site from an Italian center 128
Nail changes as manifestation of systemic disease in COVID‐19 infection 128
Dermoscopic patterns of intradermal naevi 127
The Role of Teledermatology During the COVID-19 Pandemic: A Narrative Review 126
Oral isotretinoin for acne: a complete overview 126
Dermoscopic assessment of long-term systemic therapy with dupilumab in adult atopic dermatitis 125
Efficacy and safety of vismodegib in patients with basal cell carcinoma: An Italian Center experience 123
Low-Dose Vismodegib as Maintenance Therapy After Locally Advanced Basal Cell Carcinoma Complete Remission: High Efficacy with Minimal Toxicity 123
Teledermatology for acne during COVID-19: high patients' satisfaction in spite of the emergency 122
It Is Not as It Seems 121
COVID-19 and cutaneous manifestations: A review of the published literature 120
Teledermatology: a useful tool also after Covid-19 era? 120
Efficacy and safety of sonidegib for the management of basal cell carcinoma: a drug safety evaluation 119
Adalimumab versus Rifampicin Plus Clindamycin for the Treatment of Moderate to Severe Hidradenitis Suppurativa: A Retrospective Study 119
Drug safety evaluation of ixekizumab for psoriasis: a review of the current knowledge 117
Reply to 'Cutaneous adverse effects of the available COVID-19 vaccines in India: A questionnaire-based study' by Bawane J et al 116
Real-Life Effectiveness of Vismodegib in Patients with Metastatic and Advanced Basal Cell Carcinoma: Characterization of Adverse Events and Assessment of Health-Related Quality of Life using the Dermatology Life Quality Index (DLQI) Test 115
Dermatophytid evaluated by in vivo reflectance confocal microscopy: a new approach? 113
Long-Term Efficacy of Vismodegib After its Withdrawal and Patients’ Health-Related Quality of Life Using the Dermatology Life Quality Index (DLQI) 112
Cutaneous melanoma associated with naevi prevalence: A 15-year cross-sectional retrospective study 112
Assessment of the adverse events related to hedgehog pathway inhibitor therapy for basal cell carcinoma: A single-centre retrospective study 112
Efficacy and Safety of Cemiplimab for the Management of Non-Melanoma Skin Cancer: A Drug Safety Evaluation 111
Tinea Capitis in Campania: A 5-Year Retrospective Study in Childhood and Adolescence (2013-2018). 111
Teledermatology and chronic skin diseases: real life experience in a Southern Italian Dermatologic Centre 109
Patients with bullous disorders during COVID-19 period: Management and adherence to treatment 109
Reflectance confocal microscopy for Kaposi's sarcoma treatment monitoring after intralesional vincristine chemotherapy 109
Unaddressed Challenges in the Treatment of Cutaneous Melanoma? 108
Long-term efficacy of telemedicine for patients with locally advanced basal cell carcinoma during COVID-19 pandemic 107
Effects of COVID-19 pandemic on malignant melanoma diagnosis 107
Efficacy and safety of ustekinumab in a group of 22 elderly patients with psoriasis over a 2-year period 107
Systemic Treatment of Pediatric Psoriasis: A Review. 105
Dietary intervention in acne management: review of the literature and future prospective 104
The impact of COVID-19 pandemic on nonmelanoma skin cancers: report of a Southern Italy referral centre 104
Teledermatology for acne patients: How to reduce face-to-face visits during COVID-19 pandemic 104
Cemiplimab for the treatment of advanced cutaneous squamous cell carcinoma 104
The remarkable increase of squamous cell carcinomas: a retrospective single-center study of 14-years study period 102
Dermoscopy and reflectance confocal microscopy of Kaposi's sarcoma: an overview 101
Comment on: “Clinical characteristics of patients with pityriasis rubra pilaris following SARS‐CoV‐2 vaccination” by Gambichler 100
Teledermatology for Common Inflammatory Skin Conditions: The Medicine of the Future? 99
Alopecia universalis improvement following risankizumab in a psoriasis patient 99
The Impact of COVID-19 Vaccination on Inflammatory Skin Disorders and Other Cutaneous Diseases: A Review of the Published Literature 98
Reply to Wong C et al. "Comparison of daily dosing vs. Monday through Friday dosing of vismodegib for locally advanced basal cell carcinoma (laBCC) and basal cell nevus syndrome: a retrospective case series" 97
Letter to the editor regarding article "Gu L, Diaz SM, Lipner SR. Retrospective study of acne telemedicine and in-person visits at an academic center during the COVID-19 pandemic. J Cosmet Dermatol. 2022;21(1):36-38." 96
Reply to ‘Impact of the French COVID ‐19 pandemic lockdown on newly diagnosed melanoma delay and severity’ by R. Molinier et al 94
COVID-19 vaccination and inflammatory skin diseases 94
Climate change and the role of dermatologists: a call to action 93
Hedgehog inhibitors in the treatment of advanced basal cell carcinoma: risks and benefits 93
Adalimumab biosimilar in a pediatric patient: clinical and in vivo reflectance confocal microscopy evaluation 92
A Case of Recalcitrant Circinate Generalized (Lapière) Psoriasis Successfully Treated with Risankizumab 92
Complete remission of an advanced basal cell carcinoma after only 3-month treatment with sonidegib: Report of a case and drug management during COVID-19 pandemic 91
Development of a Patient-Reported Outcome Measure (PROM) for Dysgeusia During Treatment With Smoothened (SMO) Inhibitors for Basal Cell Carcinomas: The SMO-iD Questionnaire 90
Bimekizumab treatment in patients with moderate to severe plaque psoriasis: a drug safety evaluation 90
The Past, the Present and the Future of Teledermatology: A Narrative Review 90
Comment on: “Second primary melanomas in a cohort of 977 melanoma patients within the first 5 years of monitoring” 88
Editorial: New strategies for the treatment of advanced melanoma and non-melanoma skin cancer 87
Systemic Treatment of Adult Atopic Dermatitis: A Review 86
Strategies to Improve Outcomes of Bullous Pemphigoid: A Comprehensive Review of Clinical Presentations, Diagnosis, and Patients' Assessment 86
Cutaneous Squamous Cell Carcinoma: From Diagnosis to Follow-Up 85
Trends in epidemiology of melanoma in situ in a center of South-Italy: Data from a melanoma reference center during the period 2004–2018 84
Resistance to hedgehog inhibitors in basal cell carcinoma: strategies to adopt 84
Comment on 'Development of Chilblains Lesions During the COVID-19 Pandemic is Strongly Associated with Cold Weather: Retrospective Analysis of Patients from a Single Center in the United States' 83
Maskne prevalence and risk factors during the COVID-19 pandemic 83
Telemedicine and support groups could be used to improve adherence to treatment and health-related quality of life in patients affected by inflammatory skin conditions during the COVID-19 pandemic 83
Second primary melanoma: incidence rate and risk factors 82
Author Reply to “Comment on ChatGPT and Medical Writing in Dermatology: why should we keep writing?” by Daungsupawong et al 81
Herpes Zoster and COVID-19 Vaccination: A Narrative Review 80
Viral Reactivation Following COVID-19 Vaccination: a review of the current literature 79
Cutaneous adverse reaction following COVID-19 vaccination: Report from a southern Italian referral centre. Comment on "cutaneous adverse reactions following the Pfizer/BioNTech COVID-19 vaccine" by Luo et al 78
Line-field confocal optical coherence tomography discloses an unexpected traumatic tattoo confirmed by histopathology following a car accident 78
An update on the current and emerging pharmacotherapies for basal cell carcinomas 77
Patient satisfaction with remote dermatology consultations during the COVID-19 pandemic. Comment on 'A qualitative assessment of patient satisfaction with remote dermatology consultations used during the UK's first wave of the COVID-19 pandemic in a single, secondary-care dermatology department' 76
Author Reply to “Comment on ChatGPT and Medical Writing in Dermatology: why should we keep writing?” by Duff et al 75
Awareness on sun protection behavior among melanoma and nonmelanoma skin cancer patients: An Italian tertiary cancer center experience 75
Letter to the editor regarding article "Hlaca N, Zagar T, Kastelan M, Peternel S, Brajac I, Prpic-Massari L. New-onset lichen planus and lichen planus flare in elderly women after COVID-19 vaccination. J Cosmet Dermatol. 2022;10.1111/jocd.15185" 74
Merkel Cell Carcinoma: Therapeutic Update and Emerging Therapies 74
ChatGPT and dermatology 73
The effectiveness of vismodegib in patients with advanced periocular basal cell carcinoma: a case series of 13 patients 73
ChatGPT and Dermatology: friends or foes? 72
Totale 11.025
Categoria #
all - tutte 43.312
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 43.312


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20214 0 0 0 0 0 0 0 0 0 0 0 4
2021/2022415 0 0 4 2 2 20 18 18 17 35 99 200
2022/2023765 102 76 19 34 104 68 7 80 115 95 41 24
2023/2024728 28 105 65 37 41 87 10 67 34 28 138 88
2024/20254.138 210 225 31 46 116 250 361 297 281 594 1.396 331
2025/20267.087 822 795 923 671 1.068 207 802 436 858 370 103 32
Totale 13.508